HLS Therapeutics Inc.
HLTRF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,918 | -$2,741 | -$4,436 | -$3,023 |
| Dep. & Amort. | $5,511 | $5,483 | $5,360 | $5,434 |
| Deferred Tax | -$62 | -$189 | -$289 | $59 |
| Stock-Based Comp. | $785 | $465 | $651 | $423 |
| Change in WC | -$739 | $1,284 | $1,949 | -$5 |
| Other Non-Cash | $899 | $302 | $308 | $317 |
| Operating Cash Flow | $2,476 | $4,604 | $3,543 | $3,205 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$64 | -$87 | -$21 | -$13 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$215 | -$1,000 | $0 | $0 |
| Investing Cash Flow | -$279 | -$1,087 | -$21 | -$13 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,441 | -$8,632 | -$3,103 | -$2,535 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$783 | -$833 | -$176 | -$5 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,220 | $0 | $0 | -$114 |
| Financing Cash Flow | -$3,444 | -$9,465 | -$3,279 | -$2,654 |
| Forex Effect | -$128 | $367 | $35 | -$622 |
| Net Chg. in Cash | -$1,375 | -$5,581 | $278 | -$84 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12,153 | $17,734 | $17,456 | $17,540 |
| End Cash | $10,778 | $12,153 | $17,734 | $17,456 |
| Free Cash Flow | $2,197 | $3,517 | $3,522 | $3,192 |